NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.6251
Delayed Data
As of Apr 24
 -0.0049 / -0.78%
Today’s Change
0.42
Today|||52-Week Range
1.30
-0.78%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.45, with a high estimate of 1.90 and a low estimate of 1.00. The median estimate represents a +131.96% increase from the last price of 0.63.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
$650.0K
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 44.44%
 
 
 
 
 
 
Growthannually 41.94%
 
 
 
 
 
 

Sales

Growthquarterly 68.83%
 
 
 
 
 
 
Growthannually 605.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account